Piramal Pharma Limited (BOM:543635)
India
· Delayed Price · Currency is INR 214.90
+2.95 (1.39%)
At close: May 13, 2025
Piramal Pharma Revenue
In the fiscal year ending March 31, 2025, Piramal Pharma had annual revenue of 92.86B INR with 13.64% growth. Piramal Pharma had revenue of 27.96B in the quarter ending March 31, 2025, with 9.55% growth.
Revenue
92.86B
Revenue Growth
+13.64%
P/S Ratio
3.24
Revenue / Employee
13.32M
Employees
6,719
Market Cap
290.39B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 92.86B | 11.15B | 13.64% |
| Mar 31, 2024 | 81.71B | 10.90B | 15.39% |
| Mar 31, 2023 | 70.82B | 3.47B | 5.16% |
| Mar 31, 2022 | 67.34B | 8.47B | 14.39% |
| Mar 31, 2021 | 58.87B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,646.93B |
| HDFC Bank | 2,728.47B |
| Tata Consultancy Services | 2,553.24B |
| Bharti Airtel | 1,627.08B |
| ICICI Bank | 2,006.54B |
| State Bank of India | 3,429.39B |
| Infosys | 1,647.16B |
| Hindustan Unilever | 631.21B |